News
TSH's new combo new drug has been approved and expect to get NHI price in Q2,2022. Its potentional market is approximately 2.8
2021.10.20
...
More
TSH Biopharm was invited to attend the online institutional investor conference hosted by IBF Securities
2021.9.27
...
More
The Company's 2021 annual general meeting approved removal of the noncompetition restrictions for directors
2021.8.20
...
More
Announcement of the Record Date of Cash Dividend
2021.8.20
...
More
Important Resolutions of 2021 Annual General Meeting
2021.8.20
...
More
The Board of Directors resolved to change the date and location of 2021 Annual Shareholders’ Meeting
2021.8.3
...
More